Home » Stocks » NUVB

Nuvation Bio, Inc. (NUVB)

Stock Price: $11.55 USD 0.53 (4.81%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 2.51B
Revenue (ttm) n/a
Net Income (ttm) -64.28M
Shares Out 216.65M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $11.55
Previous Close $11.02
Change ($) 0.53
Change (%) 4.81%
Day's Open 11.02
Day's Range 11.02 - 11.60
Day's Volume 364,944
52-Week Range 8.56 - 15.07

News

Hide News

SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition,...

Other stocks mentioned: PANA
1 month ago - GlobeNewsWire

SAN FRANCISCO--(BUSINESS WIRE)--Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333...

Other stocks mentioned: PANA
3 months ago - Business Wire

Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp. (NYSE: P...

Other stocks mentioned: ACAM, KBLM, PANA, SMMC
6 months ago - Benzinga

About NUVB

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting CDK2, CDK4, and CDK6. It is also developing NUV-868, a selective inhibitor of the BET family of epigenetic transcriptional regulators; NUV-569, a differentiated selective inhibitor of the Wee1 kinase; NUV-1182, an adenosine receptor inhibitor; and DDC platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PAR... [Read more...]

Industry
Biotechnology
Founded
2018
Stock Exchange
NYSE
Ticker Symbol
NUVB
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Nuvation Bio is 17.60, which is an increase of 52.38% from the latest price.

Price Target
$17.60
(52.38% upside)